(ATNX) – Hot Corp. News
-
Athenex (ATNX) Receives FDA CRL for Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
-
Athenex (ATNX) Reports Strategic Partnership with Chongqing Jingdong Pharmaceutical for Licensing Agreement to Develop and Commercialize KX2-391 in China
-
-
Back to ATNX Stock Lookup